TickerFacts.

Metagenomi Therapeutics, Inc. (MGX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

37.25M
Year ended 2025-12-31
2023-12-31: 3.40M2024-12-31: 33.03M2025-12-31: 37.25M37.25M
2023-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3137.25M+12.8%2026-03-05, From 2025-01-01
2024-12-3133.03Mn/c2026-03-05, From 2024-01-01
2023-12-313.40Mn/a2025-03-17, From 2023-01-01